Limited use of complementary and alternative medicine in Israeli head and neck cancer patients

Laryngoscope

Volumn 115, Issue 8, 2005, Pages 1505-1508

  Talmi, Yoav P ^a   Yakirevitch, Arkadi ^b   Migirov, Lela ^a   Horowitz, Zeev ^a   Bedrin, Lev ^a   Simon, Zvi ^a   Pfeffer, M Raphael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

Alternative medicine; Cancer; Complementary medicine; Head and neck

Indexed keywords

GINSENG EXTRACT; HERBACEOUS AGENT; NATURAL PRODUCT; SELENIUM;

ACUPUNCTURE; ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CANCER SURVIVAL; CHILD; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPNOSIS; HYPOPHARYNX CANCER; ISRAEL; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MASSAGE; MOUTH CANCER; NASOPHARYNX CANCER; PRIORITY JOURNAL; SALIVARY GLAND CANCER; STOMATITIS; THYROID CANCER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ISRAEL; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 23344438569     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000172205.31559.8d     Document Type: Article

References (25)

1. Chatwin J, Tovey P. Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature. Eur J Cancer Care (Engl) 2004;13: 210-218.
2. Cassileth BR. Complementary and alternative cancer medicine. J Clin Oncol 1999;17:44-52.
3. S. Ernst E. The role of complementary and alternative medicine in cancer. Lancet Oncol 2000;1:176-180.
4. Angell M, Kassirer JP. Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 1998; 339:839-841.
5. Ernst E, Filshie J, Hardy J. Evidence-based complementary medicine for palliative cancer care: does it make sense? Palliat Med 2003;17:704-707.
6. Ernst E. Complementary therapies in palliative cancer care. Cancer 2001;91:2181-2185.
7. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer 1998;83:777-782.
8. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.
9. Lafferty WE, Bellas A, Corage BA, et al. The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer 2004;100: 1522-530.
10. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18:2505-2514.
11. Correa-Velez I, Clavarino A, Barnett AG, Eastwood H. Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med 2003;17: 695-703.
12. Molassiotis A, Cubbin D. "Thinking outside the box": complementary and alternative therapies use in paediatric oncology patients. Eur J Oncol Nurs 2004;8:50-60.
13. van der WF, Streuli RA. Use of alternative medicine by patients with cancer in a rural area of Switzerland. Swiss Med Wkly 2003;133:233-240.
14. Kolstad A, Risberg T, Bremnes Y, et al. Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Support Care Cancer 2004;12:312-318.
15. Bernstein JH, Shuval JT. Nonconventional medicine in Israel: consultation patterns of the Israeli population and attitudes of primary care physicians. Soc Sci Med 1997;44: 1341-1348.
16. Rosen I, Azzam ZS, Levi T, et al. Patient approach and experience regarding complementary medicine: survey among hospitalized patients in a university hospital. Pharmacoepidemiol Drug Saf 2003;12:679-685.
17. Azaz-Livshits T, Muszkat M, Levy M. Use of complementary alternative medicine in patients admitted to internal medicine wards. Int J Clin Pharmacol Ther 2002;40:539-547.
18. Kitai E, Vinker S, Sandiuk A, et al. Use of complementary and alternative medicine among primary care patients. Fam Pract 1998;15:411-414.
19. Shmueli A, Shuval J. Use of complementary and alternative medicine in Israel: 2000 vs. 1993. Isr Med Assoc J 2004;6:3-8.
20. Yishai Y. Alternative medicine in Israel: a case of non-regulation. Med Law 1999;18:549-565.
21. Oberbaum M, Yaniv I, Ben Gal, Y, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001;92:684-690.
22. Yun TK. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003; 524:63-74.
23. Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324: 1180-1185.
24. Talmi YP, Roth Y, Waller A, et al. Care of the terminal head and neck cancer patient in the hospice setting. Laryngoscope 1995;105:315-318.
25. Talmi YP, Waller A, Bercovici M, et al. Pain experienced by patients with terminal head and neck carcinoma. Cancer 1997;80:1117-1123.